Jensen Astrid B, Hubálek Franta, Stidsen Carsten Enggaard, Johansson Eva, Öberg Fredrik Kryh, Skjøt Michael, Kjeldsen Thomas
Novo Nordisk, A/S Novo Nordisk Park, DK-2760, Måløv, Denmark.
Novo Nordisk, A/S Novo Nordisk Park, DK-2760, Måløv, Denmark.
Protein Expr Purif. 2021 Oct;186:105910. doi: 10.1016/j.pep.2021.105910. Epub 2021 Jun 2.
Expression of recombinant proteins traditionally require a cellular system to transcribe and translate foreign DNA to a desired protein. The process requires special knowledge of the specific cellular metabolism in use and is often time consuming and labour intensive. A cell free expression system provides an opportunity to express recombinant proteins without consideration of the living cell. Instead, a cell free system relies on either a cellular lysate or recombinant proteins to carry out protein synthesis, increasing overall production speed and ease of handling. The one-pot cell free setup is commonly known as an in vitro transcription/translation reaction (IVTT). Here we focused on a PURE (Protein synthesis Using Recombinant Elements) IVTT system based on recombinant proteins from Escherichia coli. We evaluated the cell free system's ability to express functional insulin analogues compared to Saccharomyces cerevisiae, a well-established system for large scale production of recombinant human insulin and insulin analogues. Significantly, it was found that correct insulin expression and folding was governed by the inherent properties of the primary amino acids sequence of insulin, whereas the eukaryotic features of the expression system apparently play a minor role. The IVTT system successfully produced insulin analogues identical in structure and with similar insulin receptor affinity to those produced by yeast. In conclusion we demonstrate that the PURE IVTT system is highly suited for expressing soluble molecules with higher order features and multiple disulphide bridges.
传统上,重组蛋白的表达需要一个细胞系统来将外源DNA转录并翻译成所需的蛋白质。这个过程需要对所使用的特定细胞代谢有专门的知识,而且往往既耗时又费力。无细胞表达系统提供了一个无需考虑活细胞就能表达重组蛋白的机会。相反,无细胞系统依靠细胞裂解物或重组蛋白来进行蛋白质合成,可以提高整体生产速度并便于操作。单罐无细胞装置通常称为体外转录/翻译反应(IVTT)。在这里,我们重点研究了基于大肠杆菌重组蛋白的PURE(使用重组元件进行蛋白质合成)IVTT系统。与酿酒酵母(一种用于大规模生产重组人胰岛素和胰岛素类似物的成熟系统)相比,我们评估了无细胞系统表达功能性胰岛素类似物的能力。值得注意的是,研究发现胰岛素的正确表达和折叠受胰岛素一级氨基酸序列固有特性的支配,而表达系统的真核特征显然只起次要作用。IVTT系统成功地生产出了结构与酵母生产的胰岛素类似物相同、胰岛素受体亲和力也相似的胰岛素类似物。总之,我们证明PURE IVTT系统非常适合表达具有高级结构特征和多个二硫键的可溶性分子。